GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Biliary Tract Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Lu Wang, M.D.) · w.lr@hotmail.com · +86-18121299357
Contact: Principal Investigator (Yiming Zhao, M.D.)

Study leads

Yiming Zhao, M.D.
Study Director
Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Hefei, China

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Advanced Malignant Solid Neoplasm · Advanced Biliary Tract Carcinoma · Advanced Esophageal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Portland, United States

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Amyloidosis · Basal Cell Carcinoma · Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Jacksonville, United States

Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma

Unresectable Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Zhengzhou, China